The final U.S. Medicare national coverage determination for transcatheter tricuspid valve replacement (TTVR) devices comes with an expected coverage with evidence development mandate, but some ...

Cash and cash equivalents, term deposits and financial assets was RMB 708 million (US$ 98 million), which remained robust and sufficient, safeguarding the commercialization of its core products ...

BEIJING, March 25, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs and is entering ...